Washington:
The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
It said GSK was the only company to make a bid for the contract, which will consist of supporting "military locations and personnel throughout the continental US and outside the continental US."
The work will be carried out in North Carolina "with an estimated completion date of Feb. 28, 2021," the Pentagon said.
The US Army will supervise execution of the project.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Advertisement
COMMENTS
Advertisement
India Is A "Strategic Partner", Says Pentagon US Approves Sale Of F-16 Parts Worth $80 Million To Taiwan Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled" 'Entire NEET Paper Solved In 45 Minutes Before Exam?': Top Court To Centre "Had God On My Side": Donald Trump Recounts Being Shot At During Rally 32 Dead In Bangladesh Unrest, Protesters Set Fire To State TV Headquarters "Every Time I Try To Eat Healthy" - Video Creator's Editing Skills Amaze Internet Watch: Comedian's Wholesome Interaction With Indian-Origin Woman Is Viral Donald Trump Accepts Republican Nomination Amid Chants Of USA From Crowd Track Latest News Live on NDTV.com and get news updates from India and around the world.